Greencap (GCG)

Shares / Stock Code

GCG

Stock Exchange / Sharemarket

ax

Greencap (GCG), formerly Acuron, sets out to withdraw itself from its original business involvement in the Vacutex capillary wound care dressing. The company now focuses on its investment activity on Australia's Small Medium Enterprise (SME) market sector. GCG's immediate focus will be the acquisition of businesses in the Risk Management service sector: Noel Arnold & Associates Pty Ltd and ENV Australia Pty Ltd.

On January 27, 2009, the Company completed the disposal of 75% of its equity interest in Protex Healthcare (UK) Limited. On 12 May 2009, the Company through its wholly owned subsidiary Noel Arnold & Associates Pty Ltd completed the purchase of the business of MC2 Pacific Pty Ltd.

Greencap is the parent entity to a number of successful, well established Small Medium Enterprises (SME's) in the Risk Management area. The companys's tag line is "protecting people, property and environments" and they deliver the risk management services via their group companies which are well regarded in the risk management industry. Its market cap is approx $32 million and Greencap has net assets as at 31 December 2009 of $56 million, 1800 shareholders, 420 employees with 16 offices covering all mainland states. The Greencap group provides services to over 5,000 clients.

Greencap History

AVP is an Australian listed healthcare investment company that was listed on the ASX in January 1987. Its head office is situated in Herdsman, Western Australia. In July 2007, AVP changed its name and business origin to Greencap Limited (GCG) focusing on investment activity on Australia's Small Medium Enterprise (SME) market sector.